Providing hepatitis B vaccination to injection drug users: Referral to health clinics vs on-site vaccination at a syringe exchange program

Injection drug users (IDU) are at a very high risk for infection with hepatitis B virus through multiperson use of injection equipment and through unprotected sexual contact. Although there are vaccines for the disease, there are multiple problems vaccinating IDUs in the US due to discrimination by...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of public health (1971) Vol. 91; no. 11; pp. 1791 - 1792
Main Authors DES JARLAIS, Don C, FISHER, Dennis G, NEWMAN, Jessica Clark, TRUBATCH, Beth N, YANCOVITZ, Molly, PAONE, Denisa, PERLMAN, David
Format Journal Article
LanguageEnglish
Published Washington, DC American Public Health Association 01.11.2001
American Journal of Public Health 2001
Subjects
Alaska
Biological and medical sciences
Cohort analysis
Community Health Centers
Discrimination
Drug use
Ethics
Health care
Hepatitis B
Hepatitis B - etiology
Hepatitis B - prevention & control
Hepatitis B Vaccines - administration & dosage
Hepatitis B virus
Human viral diseases
Humans
Immunization
Immunization Programs - organization & administration
Infectious diseases
Influenza
Injections
Longitudinal Studies
Medical sciences
Needle exchange programs
Onsite
Public health
Referral and Consultation
Research Brief
Substance Abuse, Intravenous - complications
Tuberculosis
Vaccines
Viral diseases
Viral hepatitis
New York
Alaska
United States
North America
America
United States > US
Human
Sanitary program
Drug addiction
Intravenous administration
Vaccination
Hepatic disease
Infection
Exchange
Viral hepatitis B
Prevention
Immunoprophylaxis
Viral disease
Syringe
Digestive diseases
Comparative study
Public health
Online AccessGet full text

Cover

More Information
Summary:Injection drug users (IDU) are at a very high risk for infection with hepatitis B virus through multiperson use of injection equipment and through unprotected sexual contact. Although there are vaccines for the disease, there are multiple problems vaccinating IDUs in the US due to discrimination by health care providers.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Peer Reviewed
Requests for reprints should be sent to Don C. Des Jarlais, PhD, Beth Israel Medical Center/CDI, 1st Ave and 16th St, New York, NY 10003 (e-mail: dcdesjarla@aol.com).
D. C. Des Jarlais, D. G. Fisher, and J. C. Newman conceived and developed the idea for the brief; developed and refined its content; wrote the first draft and subsequent drafts; discussed the ideas at scientific meetings worldwide; and contributed historical, ethical, and editorial expertise. J. C. Newman and M. Yancovitz in New York and B. N. Trubatch in Alaska coordinated the project, contributed to early and final drafts, provided historical expertise, and coordinated various aspects of supervision of data collection. D. Paone and D. Perlman conceived and developed the idea for the report, developed and refined the intellectual content, wrote and edited numerous drafts, and contributed historical and ethical expertise.
ISSN:0090-0036
1541-0048
DOI:10.2105/AJPH.91.11.1791